申请人:Stratatech Corporation
公开号:US10918768B2
公开(公告)日:2021-02-16
The present invention relates generally to compositions for wound closure. More specifically, the present invention provides human skin equivalents engineered to express exogenous polypeptides (e.g., antimicrobial polypeptides and keratinocyte growth factor 2) and compositions and methods for making human skin equivalents engineered to express exogenous polypeptides. In addition, the present invention provides methods for treatment of wounds with human skin equivalents engineered to express exogenous polypeptides.
本发明一般涉及用于伤口闭合的组合物。更具体地说,本发明提供了工程化表达外源多肽(如抗菌多肽和角质细胞生长因子2)的人皮等效物,以及制造工程化表达外源多肽的人皮等效物的组合物和方法。此外,本发明还提供了用工程化表达外源多肽的人体皮肤等效物治疗伤口的方法。